Literature DB >> 12847715

Regulation of Th2 cytokine gene transcription.

P Lavender1, D Cousins, T Lee.   

Abstract

Because of the different functions of IL-4, IL-13 and IL-5, it would perhaps be surprising if common transcriptional mechanisms occur. However, because of the physical proximity of their genes within the human 5q locus, chromatin remodelling during T-cell differentiation may make transcription of all the genes permissible. If co-ordinate regulation were to take place, it might be argued that similar factors might be involved in expression of all of the cytokines. Emerging data on c-Maf and GATA3 regulation of IL-4 and IL-5 respectively argues that diverse proteins may be required for transcriptional activation. Alternatively, these factors may be responsible for regulating transcriptional competence, allowing fine control over generation of particular cytokines depending upon recognition of physiological cues. If competent for transcription, common factors, such as members of the NFAT and/or AP-1 families, may operate to regulate cytokine levels. To support this, we have recently identified a conserved palindrome located within the promoters of the different Th2-type cytokines, which acts as an enhancer of transcription. Central to the capacity to express Th2 cytokines is likely to be the ability to remodel chromatin at the locus. It remains to be determined whether a single factor, or combination of factors acts to regulate this event. It is also unclear what the boundaries of remodelling within the locus are, i.e. whether IL-4 and IL-13 may be within open chromatin and IL-5 in a closed environment, and whether there is a hierarchy which determines whether particular cytokines are preferentially expressed irrespective of competence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12847715     DOI: 10.1159/000058813

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


  7 in total

1.  Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change.

Authors:  Ewen Gallagher; Min Gao; Yun-Cai Liu; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

2.  Identification of novel genes expressed during mouse tooth development by microarray gene expression analysis.

Authors:  Trevor J Pemberton; Fang-Yuan Li; Shoji Oka; Gustavo A Mendoza-Fandino; Ya-Hsuan Hsu; Pablo Bringas; Yang Chai; Malcolm L Snead; Ruty Mehrian-Shai; Pragna I Patel
Journal:  Dev Dyn       Date:  2007-08       Impact factor: 3.780

3.  Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.

Authors:  Tsung-Chieh Shih; Sen-Yung Hsieh; Yi-Yueh Hsieh; Tse-Chin Chen; Chien-Yu Yeh; Chun-Jung Lin; Deng-Yn Lin; Cheng-Tang Chiu
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 4.  Stratified approaches to the treatment of asthma.

Authors:  Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

5.  Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure.

Authors:  Yanrong Zhang; Santiago Cuevas; Laureano D Asico; Crisanto Escano; Yu Yang; Annabelle M Pascua; Xiaoyan Wang; John E Jones; David Grandy; Gilbert Eisner; Pedro A Jose; Ines Armando
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

6.  Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.

Authors:  Daniel S Chen; Yoav Soen; Tor B Stuge; Peter P Lee; Jeffrey S Weber; Patrick O Brown; Mark M Davis
Journal:  PLoS Med       Date:  2005-09-20       Impact factor: 11.069

7.  Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors.

Authors:  Andreas Nitsche; Meixia Zhang; Theresa Clauss; Wolfgang Siegert; Kay Brune; Andreas Pahl
Journal:  BMC Immunol       Date:  2007-08-31       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.